11/22
02:11 am
sgmt
Sagimet Biosciences (NASDAQ:SGMT) was downgraded by analysts at
Wall Str
Low
Report
Sagimet Biosciences (NASDAQ:SGMT) was downgraded by analysts at
Wall Str
11/22
02:11 am
sgmt
Sagimet Biosciences (NASDAQ:SGMT) was downgraded by analysts at
Wall Str
Low
Report
Sagimet Biosciences (NASDAQ:SGMT) was downgraded by analysts at
Wall Str
11/20
07:50 am
sgmt
Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference [Yahoo! Finance]
Medium
Report
Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference [Yahoo! Finance]
11/20
07:00 am
sgmt
Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference
Medium
Report
Sagimet Biosciences to Participate in the 8th Annual Evercore ISI Healthcare Conference
11/18
05:53 am
sgmt
Sagimet Biosciences Advances Denifanstat: Q3 Earnings And Upcoming Catalysts [Seeking Alpha]
Low
Report
Sagimet Biosciences Advances Denifanstat: Q3 Earnings And Upcoming Catalysts [Seeking Alpha]
11/14
10:32 am
sgmt
Sagimet Biosciences (NASDAQ:SGMT) had its price target raised by analysts at Citizens Jmp from $33.00 to $35.00. They now have a "market outperform" rating on the stock.
Low
Report
Sagimet Biosciences (NASDAQ:SGMT) had its price target raised by analysts at Citizens Jmp from $33.00 to $35.00. They now have a "market outperform" rating on the stock.
11/14
07:53 am
sgmt
Sagimet Biosciences (NASDAQ:SGMT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Low
Report
Sagimet Biosciences (NASDAQ:SGMT) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
11/14
07:22 am
sgmt
Sagimet Biosciences (NASDAQ:SGMT) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Sagimet Biosciences (NASDAQ:SGMT) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
11/13
12:07 pm
sgmt
Sagimet Biosciences GAAP EPS of -$0.40 misses by $0.01 [Seeking Alpha]
Low
Report
Sagimet Biosciences GAAP EPS of -$0.40 misses by $0.01 [Seeking Alpha]
11/13
07:30 am
sgmt
Sagimet Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Medium
Report
Sagimet Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
11/10
07:00 am
sgmt
Sagimet Biosciences Presents Two Denifanstat Posters at AASLD—The Liver Meeting® 2025
High
Report
Sagimet Biosciences Presents Two Denifanstat Posters at AASLD—The Liver Meeting® 2025
10/24
07:00 am
sgmt
Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference
High
Report
Denifanstat Achieved All Endpoints in the Treatment of Moderate to Severe Acne in Phase 3 Clinical Trial in Acne in China: A Presentation at the 2025 Fall Clinical Dermatology Conference
10/19
01:06 am
sgmt
Sagimet Biosciences (NASDAQ:SGMT) was upgraded by analysts at
Wall Stree
Medium
Report
Sagimet Biosciences (NASDAQ:SGMT) was upgraded by analysts at
Wall Stree
10/16
06:39 am
sgmt
Sagimet Biosciences (NASDAQ:SGMT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Low
Report
Sagimet Biosciences (NASDAQ:SGMT) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
10/14
07:53 am
sgmt
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences [Yahoo! Finance]
Low
Report
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences [Yahoo! Finance]
10/14
07:00 am
sgmt
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
Low
Report
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
10/14
06:22 am
sgmt
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration [Yahoo! Finance]
Neutral
Report
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration [Yahoo! Finance]
10/14
06:00 am
sgmt
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration
Low
Report
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration
10/14
06:00 am
sgmt
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration
Low
Report
Ascletis Completes Denifanstat (ASC40) Pre-NDA Consultation with China National Medical Products Administration
10/11
01:09 am
sgmt
Sagimet Biosciences (NASDAQ:SGMT) was downgraded by analysts at
Wall Str
Low
Report
Sagimet Biosciences (NASDAQ:SGMT) was downgraded by analysts at
Wall Str
10/7
09:31 am
sgmt
Denifanstat Advances: Sagimet Builds Momentum Toward 2026 Readouts [Seeking Alpha]
Low
Report
Denifanstat Advances: Sagimet Builds Momentum Toward 2026 Readouts [Seeking Alpha]
10/7
07:00 am
sgmt
Sagimet Biosciences Announces Upcoming Presentation at AASLD—The Liver Meeting® 2025
Low
Report
Sagimet Biosciences Announces Upcoming Presentation at AASLD—The Liver Meeting® 2025
10/2
08:31 am
sgmt
Sagimet Biosciences (NASDAQ:SGMT) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $28.00 price target on the stock.
Low
Report
Sagimet Biosciences (NASDAQ:SGMT) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $28.00 price target on the stock.
10/1
07:38 am
sgmt
Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination [Yahoo! Finance]
Low
Report
Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination [Yahoo! Finance]
10/1
07:00 am
sgmt
Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination
Neutral
Report
Sagimet Biosciences Announces Dosing of First Participants in Phase 1 PK Clinical Trial for Denifanstat and Resmetirom Combination